PIM3 Antibody

Code CSB-PA771444LA01HU
Size US$166
Order now
Image
  • Western Blot
    Positive WB detected in: Mouse stomach tissue
    All lanes: PIM3 antibody at 3.4μg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 36 kDa
    Observed band size: 36 kDa

  • Immunohistochemistry of paraffin-embedded human brain tissue using CSB-PA771444LA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human liver cancer using CSB-PA771444LA01HU at dilution of 1:100

  • Immunofluorescent analysis of HepG2 cells using CSB-PA771444LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) PIM3 Polyclonal antibody
Uniprot No.
Target Names
PIM3
Alternative Names
Kid 1 antibody; Kid1 antibody; Kinase induced by depolarization antibody; ONCOGENE PIM3 antibody; PIM 3 antibody; Pim 3 oncogene antibody; Pim-3 proto-oncogene; serine/threonine kinase antibody; PIM3 antibody; Pim3 oncogene antibody; PIM3_HUMAN antibody; Protein kinase Kid 1 antibody; Protein kinase Kid1 antibody; Serine/threonine kinase Pim 3 antibody; Serine/threonine kinase Pim3 antibody; Serine/threonine protein kinase Pim 3 antibody; Serine/threonine protein kinase Pim3 antibody; Serine/threonine-protein kinase Pim-3 antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse
Immunogen
Recombinant Human Serine/threonine-protein kinase pim-3 protein (278-326AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The PIM3 Antibody (Product code: CSB-PA771444LA01HU) is Non-conjugated. For PIM3 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA771444LB01HU PIM3 Antibody, HRP conjugated ELISA
FITC CSB-PA771444LC01HU PIM3 Antibody, FITC conjugated
Biotin CSB-PA771444LD01HU PIM3 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
IHC 1:20-1:200
IF 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Proto-oncogene with serine/threonine kinase activity that can prevent apoptosis, promote cell survival and protein translation. May contribute to tumorigenesis through: the delivery of survival signaling through phosphorylation of BAD which induces release of the anti-apoptotic protein Bcl-X(L), the regulation of cell cycle progression, protein synthesis and by regulation of MYC transcriptional activity. Additionally to this role on tumorigenesis, can also negatively regulate insulin secretion by inhibiting the activation of MAPK1/3 (ERK1/2), through SOCS6. Involved also in the control of energy metabolism and regulation of AMPK activity in modulating MYC and PPARGC1A protein levels and cell growth.
Gene References into Functions
  1. show that PIM1 contributes to melanoma cell proliferation and tumor growth in vivo; however, the presence of PIM2 and PIM3 could also influence the outcome. PMID: 27448973
  2. These results demonstrate the involvement of PIM kinases in LIF-induced regulation in different trophoblastic cell lines which may indicate similar functions in primary cells. PMID: 28729093
  3. PIM kinases in classical Hodgkin lymphoma exhibit pleiotropic effects, orchestrating tumor immune escape and supporting Reed-Sternberg cell survival. PMID: 28698206
  4. Our study suggests that up-regulation of Pim-3 successfully accelerated Chronic Obstructive Pulmonary Disease development, and aggravated lung damage PMID: 28214201
  5. High PIM3 expression is associated with osteosarcoma. PMID: 27826617
  6. The expression status of Pim-3 mRNA was significantly associated with pathological parameters such as pre-surgery prostate specific antigen, Gleason score, pathological stage, and lymphoid metastasis. PMID: 27826135
  7. Pim-3 expression was inversely correlated with that of miR-377. PMID: 27638830
  8. SSRP1/Ets-1/Pim-3 signalling is tightly associated with the proliferation, apoptosis, autophagy, invasion and clonogenicity of nasopharyngeal carcinoma cells, and blockage of this signalling facilitates chemosensitivity of the cells to docetaxel. PMID: 27525970
  9. Pim-3 expression showed a positive correlation with tumor cell differentiation. PMID: 26768612
  10. Pim-3 has a role in human pancreatic cancer cell survival against radiation PMID: 27016481
  11. A high percentage of urothelial carcinomas express Pim kinases. Pim expression differs in NILG, NIHG, and IHG lesions. PMID: 26551340
  12. MicroRNA506 participates in pancreatic cancer pathogenesis by targeting PIM3 PMID: 26238203
  13. Pim-3 kinase enhances growth and metastatic properties of prostate cancer xenografts. PC-3 prostate cancer cells overexpressing either Pim-1 or Pim-3 kinases form larger xenograft tumors than the parental PC-3 cells. PMID: 26075720
  14. Knockdown of Pim-3 by specific shRNA slowed decreased proliferation, induced cell cycle arrest in the G0/G1 phase, and increased apoptosis in glioblastoma cells. PMID: 25817345
  15. PIM3 expression is higher in ovarian cancer than in normal ovarian tissue. Upregulation of PIM3 promotes proliferation and migration of ovarian cancer cells. PMID: 25921139
  16. Data demonstrate the role of PIM kinases in driving myeloid leukemia, and as candidate molecules for therapy against human malignancies. PMID: 25238262
  17. we constructed a dual-function small hairpin RNA (shRNA) vector containing an shRNA targeting Pim-3 and a TLR7-stimulating ssRNA. PMID: 24723452
  18. Blocking the activities of PIM kinases(PIM1, PIM2 and PIM3) could prevent pancreatic cancer development. PIM kinases(PIM1, PIM2 and PIM3) may be a novel target for cancer therapy PMID: 24799066
  19. cancer development and in promoting tumor neovascularization and subsequent tumor growth. Targeting Pim-3 may play a dual role in halting tumor progression, by promoting tumor cell death and blocking angiogenesis PMID: 24789328
  20. Our study indicates that the expression of Pim kinases is physiologically related to DNA-PKcs and ATM in ECs. PMID: 22282239
  21. observations indicate that TCTP enhances Pim-3 stability to simultaneously promote and prevent cell-cycle progression and apoptosis, respectively PMID: 24165482
  22. the existence of different patterns of expression of Pim-3, c-Myc, and p-p27 and their clinicopathologic correlations in adenocarcinomas of the gastric cardia and the distal stomach. PMID: 24488669
  23. Pim-1 and Pim-3 play overlapping but non-identical roles as it relates to gemcitabine sensitivity of pancreatic cancer cells and Pim-3 is upregulated in pancreatic ductal carcinoma. PMID: 23760491
  24. Pim-3 can promote pancreatic tumor growth and angiogenesis by stimulating the VEGF pathway. PMID: 23845873
  25. PIM kinases promote the production of IFNgamma, the hallmark cytokine produced by Th1 cells. PMID: 23209281
  26. Pim protein kinase-3 is regulated by TNF-alpha and promotes endothelial cell sprouting. PMID: 21870113
  27. Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas. PMID: 21646687
  28. Ginsenoside Rg3 decreased both Pim-3 and pBad expressions in a dose-dependent manner in PANC-1 cells. PMID: 19624871
  29. A cell-based test system useful for rapid and inexpensive pre-screening of compounds capable of preventing Pim-mediated phosphorylation is discussed. PMID: 20939820
  30. Pim-3 has an important role in modulating c-Myc and PGC-1alpha protein levels and cell growth PMID: 21187426
  31. Pim-3 alone cannot cause, but can accelerate HCC development. PMID: 20101231
  32. Aberrnntly expressed Pim-3 can cause autonomous cell proliferation or prevent apoptosis in hepatoma cell lines. PMID: 15540201
  33. Pim kinases promote cell cycle progression and tumorigenesis by down-regulating p27(Kip1) expression at both transcriptional and posttranslational levels. PMID: 18593906
  34. Ets-1 can induce aberrant Pim-3 expression and subsequently prevent apoptosis in human pancreatic cancer cells. PMID: 19154409
  35. expression of Pim-1 & Pim-3 is induced in response reactivation in KSHV-infected cells; they are required for KSHV reactivation under these conditions; data indicate Pim-1 & Pim-3 contribute to viral reactivation by phosphorylating the KSHV LANA PMID: 19266083

Show More

Hide All

Subcellular Location
Cytoplasm.
Protein Families
Protein kinase superfamily, CAMK Ser/Thr protein kinase family, PIM subfamily
Tissue Specificity
Detected in various tissues, including the heart, brain, lung, kidney, spleen, placenta, skeletal muscle, and peripheral blood leukocytes. Not found or barely expressed in the normal adult endoderm-derived organs such as colon, thymus, liver, or small int
Database Links

HGNC: 19310

OMIM: 610580

KEGG: hsa:415116

STRING: 9606.ENSP00000353824

UniGene: Hs.530381

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*